Celcuity, Inc. (CELC)
107.16
+1.77
(+1.68%)
USD |
NASDAQ |
Jan 21, 16:00
107.02
-0.14
(-0.13%)
After-Hours: 20:00
Celcuity Cash from Investing (Quarterly): -257.61M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Olema Pharmaceuticals, Inc. | 17.27M |
| Replimune Group, Inc. | 84.17M |
| Arrowhead Pharmaceuticals, Inc. | 72.62M |
| Cidara Therapeutics, Inc. | -176.47M |
| Cogent Biosciences, Inc. | -155.05M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -44.78M |
| Cash from Financing (Quarterly) | 330.28M |
| Free Cash Flow | -144.89M |
| Free Cash Flow Per Share (Quarterly) | -0.9429 |
| Free Cash Flow to Equity (Quarterly) | -265.80M |
| Free Cash Flow to Firm (Quarterly) | -40.28M |
| Free Cash Flow Yield | -3.05% |